Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-009319
Filing Date
2025-05-08
Accepted
2025-05-08 17:28:42
Documents
130
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3319368
2 ex19-1.htm EX-19.1 106780
3 ex23-1.htm EX-23.1 3598
4 ex23-2.htm EX-23.2 4022
5 ex31-1.htm EX-31.1 17220
6 ex31-2.htm EX-31.2 17086
7 ex32-1.htm EX-32.1 10938
8 form10-k_001.jpg GRAPHIC 44895
9 form10-k_002.jpg GRAPHIC 77028
10 form10-k_003.jpg GRAPHIC 46401
  Complete submission text file 0001641172-25-009319.txt   16850092

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE celu-20241231.xsd EX-101.SCH 135918
12 XBRL CALCULATION FILE celu-20241231_cal.xml EX-101.CAL 122506
13 XBRL DEFINITION FILE celu-20241231_def.xml EX-101.DEF 641581
14 XBRL LABEL FILE celu-20241231_lab.xml EX-101.LAB 981092
15 XBRL PRESENTATION FILE celu-20241231_pre.xml EX-101.PRE 798247
132 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2635187
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38914 | Film No.: 25927536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)